CUMBERLAND PHARMACEUTICALS INC. SBIR Phase II Award, September 2018
A SBIR Phase II contract was awarded to Cumberland Pharmaceuticals in September, 2018 for $1,994,205.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
1,994,205
0
Government Branch
Date Awarded
September 11, 2018
0
End Date
August 31, 2020
0
SBIR/STTR Award Recipient
Contract Number (US Government)
9R44CA228756-02
0
Award Phase
Phase II
0
Award Type
SBIR
0
Official Website
Find more entities like CUMBERLAND PHARMACEUTICALS INC. SBIR Phase II Award, September 2018
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.